Subscribe to these results:

Upcoming Workshops

For Breast Cancer

  1. Oct 7Metastatic Breast Cancer: Treatment Updates
    Register
  2. Oct13HER2-Positive Metastatic Breast Cancer: New Therapies
    Register

For Melanoma

  1. Aug17Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
    Part II of Equity. Every Patient. Every Day. Everywhere.Register

For Mesothelioma

  1. Sep20Mesothelioma: Innovative Treatment Options
    Register

Past workshops

For All Cancers

    1. What’s New in Precision Medicine
    2. How Health Care Disparities May Influence Your Cancer Treatment & Care
    3. Understanding the Role of Immunotherapy in Treating Cancer
      Part I of New Trends in Immunotherapy
    4. Taking Your Pills on Schedule: Why It Is So Important in Managing Cancer
    5. Emerging Importance of Telemedicine/Telehealth Appointments in Communicating with Your Health Care Team
    6. Cancer and Flu Shots
    7. Treatment Adherence: Taking Your Pills on Schedule – Why It Is So Important
    8. What are Biosimilars? Understanding Their Role in Cancer Treatment: Current and Future Perspectives
    9. Managing the Side Effects of Immunotherapy
      Part II of New Trends in Immunotherapy
    10. Understanding the Role of Immunotherapy in Treating Cancer
      Part I of New Trends in Immunotherapy
    11. Participating in Decisions about Your Care
      Part IV of Life with Cancer: A Guide to Getting the Best Care
    12. Understanding the Costs of Care and Your Health Care Coverage
      Part II of Life with Cancer: A Guide to Getting the Best Care
    13. Taking Your Treatment on Schedule: Its Importance in Managing Cancer
    14. Care for Your Bones During & After Cancer Treatment: Tips to Improve Bone Health
    15. Participating in Decisions about Your Care
      Part V of Life with Cancer: A Guide to Getting the Best Care
    16. Update on Clinical Trials: How They Work
    17. Managing the Side Effects of Immunotherapy
      Part II of Immunotherapy: A Promising Approach to Treating Cancer
    18. Understanding the Role of Immunotherapy in Treating Cancer
      Part I of Immunotherapy: A Promising Approach to Treating Cancer
    19. Taking Your Pills on Schedule: Its Importance in Treating Cancer
    20. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    21. Genomics and the Future of Cancer Treatment
    22. Genomics and Genetics: What is the Difference?
    23. What Are Biosimilars? Understanding Their Role in Cancer Treatments: Current and Future Perspectives
    24. Managing the Side Effects of Immunotherapy
      Part II of Immunotherapy: A Promising New Approach to Treating Cancer
    25. Understanding the Role of Immunotherapy in Treating Cancer
      Part I of Immunotherapy: A Promising New Approach to Treating Cancer
    26. Taking Your Pills on Schedule: Why It Is So Important in Managing Cancer
    27. What Are Generic Drugs: Understanding Their Role in Cancer Treatment
    28. Taking Your Pills on Schedule: The Importance of Adherence in the Treatment of Cancer
    29. Managing the Side Effects of Immunotherapy
      Part II of Immunotherapy: A Promising New Approach to Treating Cancer
    30. Understanding the Role of Immunotherapy in Treating Cancer
      Part I of Immunotherapy: A Promising New Approach to Treating Cancer
    31. What Are Biosimilars? Understanding Their Role in Cancer Treatment: Current and Future Perspectives
    32. Taking Your Pills on Schedule – Why It Is So Important in Managing Cancer
    33. Understanding the Important Role of Adherence in the Medical Management of Cancer
    34. Medical Emergencies in Cancer Treatment

For Acute Lymphoblastic Leukemia

    1. Transplantation as a Treatment Option for Blood Cancers
    2. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    3. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    4. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    5. Update on CAR-T Cell Therapy
    6. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    7. Taking Your Blood Cancer Treatment on Schedule
    8. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    9. Treatment Update for Adults Living with Acute Lymphocytic Leukemia (ALL)
    10. Treatment Update for Adults Living with Acute Lymphocytic Leukemia (ALL)
    11. New Treatments for Childhood Acute Lymphocytic Leukemia (ALL)
    12. Update on CAR-T Cell Therapy
    13. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    14. Life With Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches

For Acute Myeloid Leukemia

    1. Transplantation as a Treatment Option for Blood Cancers
    2. Update on the Treatment of Acute Myelogenous Leukemia (AML)
    3. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    4. Update on CAR T-Cell Therapies
    5. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    6. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    7. Living with Acute Myelogenous Leukemia (AML)
    8. Update on CAR-T Cell Therapy
    9. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    10. Taking Your Blood Cancer Treatment on Schedule
    11. Updates in the Treatment of Acute Myelogenous Leukemia
    12. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    13. Medical Update on Acute Myelogenous Leukemia (AML)
    14. Update on CAR-T Cell Therapy
    15. Medical Update on Acute Myelogenous Leukemia (AML)
    16. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    17. Life With Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches

For Basal Cell Cancer

    1. New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell and Squamous Cell Cancers
    2. New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell and Squamous Cell Cancers
      Part I of Life with Advanced Skin Cancer
    3. New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell and Advanced Squamous Cell Cancers
      Part I of Living with Advanced Skin Cancer

For Bladder Cancer

    1. Update on the Treatment of Bladder Cancer
      Part I of Living with Bladder Cancer
    2. What’s New in the Treatment of Bladder Cancer
      Part I of Life with Bladder Cancer
    3. Updates on the Treatment of Bladder Cancer
    4. Update on the Treatment of Bladder Cancer
      Part I of Living with Bladder Cancer

For Brain Cancer

    1. Update on Glioblastoma in Adults
    2. Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress Together
      Part I of Your Guide to the Latest Cancer Research and Treatment
    3. Update on Glioblastoma in Adults

For Breast Cancer

    1. Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part I of Equity. Every Patient. Every Day. Everywhere.
    2. Updates on the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive & HER2 Positive Breast Cancer from the 43rd Annual San Antonio Breast Cancer Symposium (SABCS)
      Part II of Life with Breast Cancer - Updates from the 43rd Annual San Antonio Breast Cancer Symposium (SABCS)
    3. The Latest Developments Reported from the 43rd Annual San Antonio Breast Cancer Symposium (SABCS)
      Part I of Life with Breast Cancer - Updates from the 43rd Annual San Antonio Breast Cancer Symposium (SABCS)
    4. Updates from the San Antonio Breast Cancer Symposium (SABCS) on Triple Negative Breast Cancer (TNBC)
    5. Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress Together
      Part I of Your Guide to the Latest Cancer Research and Treatment
    6. Triple Negative Breast Cancer and African American Women
    7. What’s New in the Treatment of Breast Cancer for Women of All Ages
    8. What’s New in the Treatment of Metastatic Breast Cancer
    9. Update on Triple Negative Breast Cancer
      Part I of Living with Triple Negative Breast Cancer
    10. Advances in the Treatment of Triple Negative Breast Cancer
      Part I of Living with Triple Negative Breast Cancer
    11. Advances in the Treatment of HER2 Positive Breast Cancer
    12. El cáncer de seno y las mujeres hispanas (Breast Cancer and Hispanic Women)

For Chronic Lymphocytic Leukemia

    1. Transplantation as a Treatment Option for Blood Cancers
    2. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    3. Update on CAR T-Cell Therapies
    4. Current Perspectives on the Treatment of Chronic Lymphocytic Leukemia (CLL)
      Part II of Living with Chronic Lymphocytic Leukemia (CLL)
    5. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    6. Update on Chronic Lymphocytic Leukemia (CLL)
      Part I of Living with Chronic Lymphocytic Leukemia (CLL)
    7. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    8. Update on CAR-T Cell Therapy
    9. Current Perspectives on the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
      Part II of Life with Chronic Lymphocytic Leukemia (CLL)
    10. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    11. Update on Chronic Lymphocytic Leukemia
      Part I of Life with Chronic Lymphocytic Leukemia (CLL)
    12. Taking Your Blood Cancer Treatment on Schedule
    13. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    14. Current Perspectives on the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
      Part II of Living with Chronic Lymphocytic Leukemia
    15. Update on Chronic Lymphocytic Leukemia
      Part I of Living with Chronic Lymphocytic Leukemia
    16. Update on Chronic Lymphocytic Leukemia (CLL)
    17. Older Persons Living with Chronic Lymphocytic Leukemia
    18. Life with CLL: Taking Charge of Your Treatment Schedule
      Part II of Life with Chronic Lymphocytic Leukemia (CLL)
    19. Managing Chronic Lymphocytic Leukemia and Its Complications
      Part I of Life with Chronic Lymphocytic Leukemia (CLL)
    20. Update on CAR-T Cell Therapy
    21. Update on Chronic Lymphocytic Leukemia (CLL)
    22. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    23. Life With Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches

For Chronic Myelogenous Leukemia

    1. Transplantation as a Treatment Option for Blood Cancers
    2. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    3. Update on CAR T-Cell Therapies
    4. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    5. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    6. Living with Chronic Myelogenous Leukemia (CML)
    7. Update on CAR-T Cell Therapy
    8. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    9. Taking Your Blood Cancer Treatment on Schedule
    10. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    11. Update on CAR-T Cell Therapy
    12. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    13. Life With Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches

For Colorectal Cancer

    1. Advances in the Treatment of Colorectal Cancer
    2. Progress in the Treatment of Colorectal Cancer
    3. Advances in the Treatment of Colorectal Cancer
    4. Update on the Treatment of Colorectal Cancer

For Cutaneous T-Cell Lymphoma

    1. Transplantation as a Treatment Option for Blood Cancers
    2. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    3. Update on Diffuse Large B-Cell Lymphoma (DLBCL)
    4. Update on CAR T-Cell Therapies
    5. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    6. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    7. Update on CAR-T Cell Therapy
    8. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    9. Taking Your Blood Cancer Treatment on Schedule
    10. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    11. Update on Cutaneous T-Cell Lymphoma
    12. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    13. The Emerging Role of Immunotherapy in the Treatment of Lymphoma
    14. Update on CAR-T Cell Therapy
    15. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    16. Update on Cutaneous T-Cell Lymphoma
    17. Life With Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    18. Advances in Immunotherapy in the Treatment of Lymphoma

For Diffuse Large B-Cell Lymphoma

    1. Update on Diffuse Large B-Cell Lymphoma (DLBCL)
    2. Update on CAR T-Cell Therapies
    3. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    4. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    5. Update on Diffuse Large B-Cell Lymphoma (DLBCL)
    6. Update on CAR-T Cell Therapy
    7. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    8. Taking Your Blood Cancer Treatment on Schedule
    9. Update on Diffuse Large B-Cell Lymphoma
    10. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    11. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    12. Update on Diffuse Large B-Cell Lymphoma
    13. The Emerging Role of Immunotherapy in the Treatment of Lymphoma
    14. Update on CAR-T Cell Therapy

For Endometrial Cancer

    1. Update on the Treatment of Endometrial Cancer

For Follicular Lymphoma

    1. Transplantation as a Treatment Option for Blood Cancers
    2. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    3. Update on Diffuse Large B-Cell Lymphoma (DLBCL)
    4. Update on CAR T-Cell Therapies
    5. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    6. Progress in the Treatment of Follicular Lymphoma
    7. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    8. Update on CAR-T Cell Therapy
    9. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    10. Taking Your Blood Cancer Treatment on Schedule
    11. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    12. Progress in the Treatment of Follicular Lymphoma
    13. The Emerging Role of Immunotherapy in the Treatment of Lymphoma
    14. Update on CAR-T Cell Therapy
    15. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    16. Progress in the Treatment of Follicular Lymphoma
    17. Life With Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    18. Advances in Immunotherapy in the Treatment of Lymphoma

For Gastric Cancer

    1. Advances in the Treatment of Gastric Cancer
    2. Advances in the Treatment of Gastric Cancer
    3. Current Perspectives in the Treatment of Metastatic Gastric Cancer
    4. Advances in the Treatment of Gastric Cancer

For Gastrointestinal Stromal Tumors

    1. Advances in the Treatment of Gastrointestinal Stromal Tumors (GIST)
    2. Living with Gastrointestinal Stromal Tumors (GIST)

For Glioblastoma

    1. Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part I of Equity. Every Patient. Every Day. Everywhere.
    2. Update on Glioblastoma in Adults
    3. Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress Together
      Part I of Your Guide to the Latest Cancer Research and Treatment
    4. Update on Glioblastoma in Adults

For Head and Neck Cancer

    1. Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part I of Equity. Every Patient. Every Day. Everywhere.
    2. Treatment Update in Oral and Head and Neck Cancer
    3. Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress Together
      Part I of Your Guide to the Latest Cancer Research and Treatment
    4. What’s New in the Treatment of Oral and Head and Neck Cancer
    5. What’s New in the Treatment of Oral and Head and Neck Cancer
    6. Genomics and What’s New in the Treatment of Oral and Head and Neck Cancer
    7. Progress in the Treatment of Oral and Head and Neck Cancer

For Hodgkin Lymphoma

    1. Transplantation as a Treatment Option for Blood Cancers
    2. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    3. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    4. Update on Diffuse Large B-Cell Lymphoma (DLBCL)
    5. Update on CAR T-Cell Therapies
    6. Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
    7. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    8. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    9. What’s New in the Treatment of Hodgkin Lymphoma
    10. Update on CAR-T Cell Therapy
    11. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    12. Taking Your Blood Cancer Treatment on Schedule
    13. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    14. Progress in the Treatment of Hodgkin Lymphoma
    15. Update on CAR-T Cell Therapy for People Living with Lymphoma
    16. The Emerging Role of Immunotherapy in the Treatment of Lymphoma
    17. Update on CAR-T Cell Therapy
    18. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    19. Progress in the Treatment of Hodgkin Lymphoma
    20. Life With Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    21. Advances in Immunotherapy in the Treatment of Lymphoma

For Kidney Cancer

    1. Advances in the Treatment of Renal Cell Cancer
    2. Advances in the Treatment of Renal Cell Cancer

For Leukemia

    1. Transplantation as a Treatment Option for Blood Cancers
    2. Progress in the Treatment of Myelofibrosis
    3. Update on the Treatment of Acute Myelogenous Leukemia (AML)
    4. Update on CAR T-Cell Therapies
    5. Current Perspectives on the Treatment of Chronic Lymphocytic Leukemia (CLL)
      Part II of Living with Chronic Lymphocytic Leukemia (CLL)
    6. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    7. Update on Chronic Lymphocytic Leukemia (CLL)
      Part I of Living with Chronic Lymphocytic Leukemia (CLL)
    8. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    9. Living with Acute Myelogenous Leukemia (AML)
    10. Progress in the Treatment of Myelodysplastic Syndrome (MDS)
    11. Living with Chronic Myelogenous Leukemia (CML)
    12. Current Perspectives on the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
      Part II of Life with Chronic Lymphocytic Leukemia (CLL)
    13. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    14. Update on Chronic Lymphocytic Leukemia
      Part I of Life with Chronic Lymphocytic Leukemia (CLL)
    15. Taking Your Blood Cancer Treatment on Schedule
    16. Updates in the Treatment of Acute Myelogenous Leukemia
    17. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    18. Current Perspectives on the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
      Part II of Living with Chronic Lymphocytic Leukemia
    19. Medical Update on Acute Myelogenous Leukemia (AML)
    20. Update on Chronic Lymphocytic Leukemia
      Part I of Living with Chronic Lymphocytic Leukemia
    21. Treatment Update for Adults Living with Acute Lymphocytic Leukemia (ALL)
    22. Older Persons Living with Chronic Lymphocytic Leukemia
    23. Life with CLL: Taking Charge of Your Treatment Schedule
      Part II of Life with Chronic Lymphocytic Leukemia (CLL)
    24. Managing Chronic Lymphocytic Leukemia and Its Complications
      Part I of Life with Chronic Lymphocytic Leukemia (CLL)
    25. Treatment Update for Adults Living with Acute Lymphocytic Leukemia (ALL)
    26. New Treatments for Childhood Acute Lymphocytic Leukemia (ALL)
    27. Medical Update on Acute Myelogenous Leukemia (AML)
    28. Update on Chronic Lymphocytic Leukemia (CLL)
    29. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    30. Life With Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches

For Liver Cancer

    1. Treatment Update on Liver Cancer
    2. Treatment Update on Liver Cancer and Managing the Cost of Care
    3. Treatment Update on Liver Cancer and Managing the Cost of Care
    4. Treatment Update on Liver Cancer

For Lung Cancer

    1. Diverse Populations Living with Non-Small Cell Lung Cancer
    2. Advances in the Treatment of Lung Cancer
      Part I of Living with Lung Cancer
    3. Update on Small Cell Lung Cancer Treatments
    4. For Caregivers: Practical Tips for Coping with Your Loved One’s Lung Cancer
      Part II of Living with Lung Cancer
    5. Progress in the Treatment of Lung Cancer
      Part I of Living with Lung Cancer
    6. Advances in the Treatment of Lung Cancer
      Part I of Life with Lung Cancer
    7. For Caregivers: Practical Tips for Coping with Your Loved One’s Lung Cancer During the Holidays
      Part II of Life with Lung Cancer
    8. Progress in the Treatment of Lung Cancer
      Part I of Life with Lung Cancer
    9. What’s New in the Treatment of Lung Cancer
      Part I of Living with Lung Cancer
    10. For Caregivers: Practical Tips for Coping with Your Loved One’s Lung Cancer
      Part II of Living with Lung Cancer
    11. What’s New in the Treatment of Lung Cancer
      Part I of Living with Lung Cancer
    12. Advances in the Treatment of Mesothelioma
    13. Advances in the Treatment of Lung Cancer
      Part I of Living With Lung Cancer
    14. Advances in the Treatment of Lung Cancer
      Part I of Living with Lung Cancer
    15. Update on Small Cell Lung Cancer Treatments
      Part I of Living with Small Cell Lung Cancer

For Lymphoma

    1. Transplantation as a Treatment Option for Blood Cancers
    2. Update on Marginal Zone Lymphoma (MZL)
    3. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    4. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    5. Update on Diffuse Large B-Cell Lymphoma (DLBCL)
    6. Update on CAR T-Cell Therapies
    7. Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
    8. Treatment Update on Mantle Cell Lymphoma (MCL)
      Part I of Living with Mantle Cell Lymphoma
    9. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    10. Progress in the Treatment of Follicular Lymphoma
    11. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    12. Update on Diffuse Large B-Cell Lymphoma (DLBCL)
    13. New Perspectives in the Treatment of Peripheral T-Cell Lymphoma (PTCL)
    14. What’s New in the Treatment of Hodgkin Lymphoma
    15. Treatment Update on Mantle Cell Lymphoma (MCL)
    16. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    17. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    18. Taking Your Blood Cancer Treatment on Schedule
    19. The Latest News in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
    20. Update on Diffuse Large B-Cell Lymphoma
    21. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    22. Progress in the Treatment of Hodgkin Lymphoma
    23. Update on Cutaneous T-Cell Lymphoma
    24. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    25. Update on Diffuse Large B-Cell Lymphoma
    26. Treatment Update on Mantle Cell Lymphoma
    27. Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
    28. Progress in the Treatment of Follicular Lymphoma
    29. Update on Marginal Zone Lymphoma
    30. Update on CAR-T Cell Therapy for People Living with Lymphoma
    31. Update on Mantle Cell Lymphoma
    32. The Emerging Role of Immunotherapy in the Treatment of Lymphoma
    33. Treatment Update on Mantle Cell Lymphoma (MCL)
    34. Progress in the Treatment of Waldenstrom’s Macroglobulinemia
    35. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    36. Update on Marginal Zone Lymphoma
    37. Update on Cutaneous T-Cell Lymphoma
    38. Progress in the Treatment of Follicular Lymphoma
    39. Progress in the Treatment of Hodgkin Lymphoma
    40. Treatment Update on Mantle Cell Lymphoma (MCL)
    41. Life With Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    42. Advances in Immunotherapy in the Treatment of Lymphoma

For Mantle Cell Lymphoma

    1. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    2. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    3. Update on Diffuse Large B-Cell Lymphoma (DLBCL)
    4. Update on CAR T-Cell Therapies
    5. Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
    6. Treatment Update on Mantle Cell Lymphoma (MCL)
      Part I of Living with Mantle Cell Lymphoma
    7. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    8. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    9. Treatment Update on Mantle Cell Lymphoma (MCL)
    10. Update on CAR-T Cell Therapy
    11. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    12. Taking Your Blood Cancer Treatment on Schedule
    13. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    14. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    15. Treatment Update on Mantle Cell Lymphoma
    16. Update on Mantle Cell Lymphoma
    17. The Emerging Role of Immunotherapy in the Treatment of Lymphoma
    18. Treatment Update on Mantle Cell Lymphoma (MCL)
    19. Update on CAR-T Cell Therapy
    20. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    21. Treatment Update on Mantle Cell Lymphoma (MCL)
    22. Life With Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    23. Advances in Immunotherapy in the Treatment of Lymphoma

For Marginal Zone Lymphoma

    1. Update on Marginal Zone Lymphoma (MZL)
    2. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    3. Update on Diffuse Large B-Cell Lymphoma (DLBCL)
    4. Update on CAR T-Cell Therapies
    5. Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
    6. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    7. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    8. Update on CAR-T Cell Therapy
    9. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    10. Taking Your Blood Cancer Treatment on Schedule
    11. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    12. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    13. Update on Marginal Zone Lymphoma
    14. The Emerging Role of Immunotherapy in the Treatment of Lymphoma
    15. Update on CAR-T Cell Therapy
    16. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    17. Update on Marginal Zone Lymphoma

For Melanoma

    1. Emerging Treatments for Metastatic Melanoma
      Part II of Living with Advanced Skin Cancer and Melanoma
    2. New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell and Squamous Cell Cancers
      Part I of Living with Advanced Skin Cancer and Melanoma
    3. Emerging Treatments for Metastatic Melanoma
      Part II of Life with Advanced Skin Cancer
    4. Emerging Treatments for Metastatic Melanoma
      Part II of Living with Advanced Skin Cancer
    5. Emerging Treatments for Metastatic Melanoma
      Part II of Living with Advanced Skin Cancer

For Merkel Cell Carcinoma

    1. Treatment Perspectives on Merkel Cell Carcinoma (MCC)
      Part I of Living with Merkel Cell Carcinoma (MCC)

For Mesothelioma

    1. Advances in the Treatment of Mesothelioma
    2. Advances in the Treatment of Mesothelioma

For Metastatic Breast Cancer

    1. Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part I of Equity. Every Patient. Every Day. Everywhere.
    2. Updates on the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive & HER2 Positive Breast Cancer from the 43rd Annual San Antonio Breast Cancer Symposium (SABCS)
      Part II of Life with Breast Cancer - Updates from the 43rd Annual San Antonio Breast Cancer Symposium (SABCS)
    3. The Latest Developments Reported from the 43rd Annual San Antonio Breast Cancer Symposium (SABCS)
      Part I of Life with Breast Cancer - Updates from the 43rd Annual San Antonio Breast Cancer Symposium (SABCS)
    4. Updates from the San Antonio Breast Cancer Symposium (SABCS) on Triple Negative Breast Cancer (TNBC)
    5. Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress Together
      Part I of Your Guide to the Latest Cancer Research and Treatment
    6. What’s New in the Treatment of Breast Cancer for Women of All Ages
    7. What’s New in the Treatment of Metastatic Breast Cancer
    8. Update on Triple Negative Breast Cancer
      Part I of Living with Triple Negative Breast Cancer
    9. Advances in the Treatment of Triple Negative Breast Cancer
      Part I of Living with Triple Negative Breast Cancer
    10. Advances in the Treatment of HER2 Positive Breast Cancer

For Multiple Myeloma

    1. Transplantation as a Treatment Option for Blood Cancers
    2. Update on CAR T-Cell Therapies
    3. Progress in the Treatment of Multiple Myeloma
    4. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    5. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    6. Progress in the Treatment of Multiple Myeloma
      Part I of Life with Multiple Myeloma
    7. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    8. Taking Your Blood Cancer Treatment on Schedule
    9. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    10. Progress in the Treatment of Multiple Myeloma
    11. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    12. Progress in the Treatment of Multiple Myeloma
    13. Life With Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    14. Managing Symptoms and Treatment Side Effects of Multiple Myeloma
      Part III of Living with Multiple Myeloma

For Myelodysplastic Syndromes

    1. Transplantation as a Treatment Option for Blood Cancers
    2. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    3. Update on CAR T-Cell Therapies
    4. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    5. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    6. Progress in the Treatment of Myelodysplastic Syndrome (MDS)
    7. Taking Your Blood Cancer Treatment on Schedule
    8. Progress in the Treatment of Myelodysplastic Syndromes (MDS)

For Myelofibrosis

    1. Transplantation as a Treatment Option for Blood Cancers
    2. Progress in the Treatment of Myelofibrosis
    3. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    4. Update on CAR T-Cell Therapies
    5. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    6. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    7. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    8. Taking Your Blood Cancer Treatment on Schedule
    9. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    10. Progress in the Treatment of Myelodysplastic Syndromes (MDS)
    11. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    12. Life With Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches

For Myeloproliferative Neoplasms

    1. Transplantation as a Treatment Option for Blood Cancers
    2. Progress in the Treatment of Myelofibrosis
    3. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    4. Update on CAR T-Cell Therapies
    5. Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
    6. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    7. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    8. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    9. Taking Your Blood Cancer Treatment on Schedule
    10. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    11. Progress in the Treatment of Myelodysplastic Syndromes (MDS)
    12. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    13. Life With Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches

For Non-Hodgkin Lymphoma

    1. Transplantation as a Treatment Option for Blood Cancers
    2. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    3. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    4. Update on CAR T-Cell Therapies
    5. Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
    6. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    7. Progress in the Treatment of Follicular Lymphoma
    8. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    9. Update on CAR-T Cell Therapy
    10. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    11. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    12. Taking Your Blood Cancer Treatment on Schedule
    13. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    14. Update on Cutaneous T-Cell Lymphoma
    15. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    16. Update on Diffuse Large B-Cell Lymphoma
    17. Treatment Update on Mantle Cell Lymphoma
    18. Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
    19. Progress in the Treatment of Follicular Lymphoma
    20. Update on Marginal Zone Lymphoma
    21. Update on CAR-T Cell Therapy for People Living with Lymphoma
    22. Update on Mantle Cell Lymphoma
    23. The Emerging Role of Immunotherapy in the Treatment of Lymphoma
    24. Treatment Update on Mantle Cell Lymphoma (MCL)
    25. Progress in the Treatment of Waldenstrom’s Macroglobulinemia
    26. Update on CAR-T Cell Therapy
    27. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    28. Update on Marginal Zone Lymphoma
    29. Update on Cutaneous T-Cell Lymphoma
    30. Progress in the Treatment of Follicular Lymphoma
    31. Treatment Update on Mantle Cell Lymphoma (MCL)
    32. Life With Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    33. Advances in Immunotherapy in the Treatment of Lymphoma

For Ovarian Cancer

    1. Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part I of Equity. Every Patient. Every Day. Everywhere.
    2. Medical Update on Ovarian Cancer
    3. Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress Together
      Part I of Your Guide to the Latest Cancer Research and Treatment
    4. Medical Update on Ovarian Cancer
    5. Medical Update on Ovarian Cancer
    6. Update on Advanced Ovarian Cancer

For Pancreatic Cancer

    1. Treatment Update on Pancreatic Cancer
    2. Update on the Treatment of Pancreatic Cancer
    3. Update on the Treatment of Pancreatic Cancer

For Peripheral T-Cell Lymphoma

    1. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    2. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    3. Update on Diffuse Large B-Cell Lymphoma (DLBCL)
    4. Update on CAR T-Cell Therapies
    5. Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
    6. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    7. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    8. New Perspectives in the Treatment of Peripheral T-Cell Lymphoma (PTCL)
    9. Update on CAR-T Cell Therapy
    10. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    11. Taking Your Blood Cancer Treatment on Schedule
    12. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    13. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    14. The Emerging Role of Immunotherapy in the Treatment of Lymphoma
    15. Update on CAR-T Cell Therapy
    16. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    17. Life With Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    18. Advances in Immunotherapy in the Treatment of Lymphoma

For Polycythemia Vera

    1. Transplantation as a Treatment Option for Blood Cancers
    2. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    3. Update on CAR T-Cell Therapies
    4. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    5. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    6. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    7. Taking Your Blood Cancer Treatment on Schedule
    8. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    9. The Emerging Role of Immunotherapy in the Treatment of Lymphoma
    10. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    11. Life With Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches

For Prostate Cancer

    1. Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part I of Equity. Every Patient. Every Day. Everywhere.
    2. Advances in the Treatment of Metastatic Prostate Cancer
    3. Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress Together
      Part I of Your Guide to the Latest Cancer Research and Treatment
    4. For Caregivers: Coping with a Loved One’s Prostate Cancer
    5. Advances in the Treatment of Metastatic Prostate Cancer
      Part I of Living with Prostate Cancer

For Renal Cell Cancer

    1. Advances in the Treatment of Renal Cell Cancer
    2. Treatment Update on Renal Cell Cancer
    3. Advances in the Treatment of Renal Cell Cancer

For Sarcoma

    1. Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part I of Equity. Every Patient. Every Day. Everywhere.
    2. Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress Together
      Part I of Your Guide to the Latest Cancer Research and Treatment
    3. Update on Soft Tissue Sarcoma
    4. Update on Rare Sarcomas
    5. Update on Soft Tissue Sarcoma
    6. Living with Gastrointestinal Stromal Tumors (GIST)

For Skin Cancer

    1. Emerging Treatments for Metastatic Melanoma
      Part II of Living with Advanced Skin Cancer and Melanoma
    2. New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell and Squamous Cell Cancers
      Part I of Living with Advanced Skin Cancer and Melanoma
    3. New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell and Squamous Cell Cancers
    4. Emerging Treatments for Metastatic Melanoma
      Part II of Life with Advanced Skin Cancer
    5. New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell and Squamous Cell Cancers
      Part I of Life with Advanced Skin Cancer
    6. Treatment Perspectives on Merkel Cell Carcinoma (MCC)
      Part I of Living with Merkel Cell Carcinoma (MCC)
    7. Emerging Treatments for Metastatic Melanoma
      Part II of Living with Advanced Skin Cancer
    8. Emerging Treatments for Metastatic Melanoma
      Part II of Living with Advanced Skin Cancer
    9. New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell and Advanced Squamous Cell Cancers
      Part I of Living with Advanced Skin Cancer

For Small Lymphocytic Lymphoma

    1. Transplantation as a Treatment Option for Blood Cancers
    2. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    3. Update on CAR T-Cell Therapies
    4. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
    5. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
    6. Update on CAR-T Cell Therapy
    7. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    8. Taking Your Blood Cancer Treatment on Schedule
    9. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    10. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
    11. The Emerging Role of Immunotherapy in the Treatment of Lymphoma
    12. Update on CAR-T Cell Therapy
    13. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    14. Life With Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    15. Advances in Immunotherapy in the Treatment of Lymphoma

For Squamous Cell Cancer

    1. New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell and Squamous Cell Cancers
      Part I of Living with Advanced Skin Cancer and Melanoma
    2. New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell and Squamous Cell Cancers
    3. New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell and Squamous Cell Cancers
      Part I of Life with Advanced Skin Cancer
    4. New Perspectives in the Treatment of Advanced Skin Cancer: Advanced Basal Cell and Advanced Squamous Cell Cancers
      Part I of Living with Advanced Skin Cancer

For Stomach Cancer

    1. Current Perspectives in the Treatment of Metastatic Gastric Cancer

For Thyroid Cancer

    1. Update on Thyroid Cancer

For Triple Negative Breast Cancer

    1. Highlights from the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
      Part I of Equity. Every Patient. Every Day. Everywhere.
    2. Updates on the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive & HER2 Positive Breast Cancer from the 43rd Annual San Antonio Breast Cancer Symposium (SABCS)
      Part II of Life with Breast Cancer - Updates from the 43rd Annual San Antonio Breast Cancer Symposium (SABCS)
    3. The Latest Developments Reported from the 43rd Annual San Antonio Breast Cancer Symposium (SABCS)
      Part I of Life with Breast Cancer - Updates from the 43rd Annual San Antonio Breast Cancer Symposium (SABCS)
    4. Updates from the San Antonio Breast Cancer Symposium (SABCS) on Triple Negative Breast Cancer (TNBC)
    5. Highlights from the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting: Unite and Conquer: Accelerating Progress Together
      Part I of Your Guide to the Latest Cancer Research and Treatment
    6. Triple Negative Breast Cancer and African American Women
    7. What’s New in the Treatment of Breast Cancer for Women of All Ages
    8. Update on Triple Negative Breast Cancer
      Part I of Living with Triple Negative Breast Cancer
    9. Advances in the Treatment of Triple Negative Breast Cancer
      Part I of Living with Triple Negative Breast Cancer

For Waldenstrom’s Macroglobulinemia

    1. Transplantation as a Treatment Option for Blood Cancers
    2. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    3. Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
    4. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    5. The Latest News in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
    6. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    7. Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
    8. Progress in the Treatment of Waldenstrom’s Macroglobulinemia
    9. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
    10. Life With Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
Back to Top
Terms of Use and Privacy Policy

By using our website, you agree to our recently updated Privacy Policy . Here you can read more about our use of cookies which help us make continuous improvements to our website. Privacy Policy.